In another study, AAbs against NPM-1, 14-3-3 zeta, and MDM2 were suggested to have diagnostic value for AFP-negative HCC patients (AFP < 20 ng/mL; AFP− HCC) [6]. This evidence concerns the gene NPM1 and hepatocellular carcinoma.